Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Primary Objective • Demonstrate superior efficacy of IV tanezumab 10 mg and 5 mg alone and in combination with an NSAID PO (naproxen 500 mg BID or celecoxib 100 mg BID) versus placebo in combination with an NSAID PO (naproxen 500 mg BID or celecoxib 100 mg BID) at Week 16.
Critère d'inclusion
- OSTEOARTHRITIS OF THE KNEE OR HIP